DPH1 Antikörper (AA 251-350) (Cy3)

Produktnummer ABIN713654

Produktdetails anti-DPH1 Antikörper (Cy3)

Target: DPH1 (DPH1 Homolog (DPH1))

Bindungsspezifität: AA 251-350

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser DPH1 Antikörper ist konjugiert mit Cy3

Applikation: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Kreuzreaktivität: Human

Homologie: Mouse,Rat,Dog,Cow,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human OVCA1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu DPH1

Target: DPH1 (DPH1 Homolog (DPH1))

Andere Bezeichnung: OVCA1 (DPH1 Produkte)

Synonyme: DPH1 antikoerper, DPH1-OVCA2 antikoerper, dph1-ovca2 antikoerper, dph2l antikoerper, dph2l1 antikoerper, ovca1 antikoerper, DPH2L antikoerper, DPH2L1 antikoerper, OVCA1 antikoerper, zgc:110702 antikoerper, 2310011M22Rik antikoerper, 4930488F09Rik antikoerper, AW551873 antikoerper, Dph2l1 antikoerper, Ovca1 antikoerper, RGD1562694 antikoerper, diphthamide biosynthesis 1 antikoerper, diphthamide biosynthesis protein 1 antikoerper, diphthamide biosynthesis 1 L homeolog antikoerper, 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 antikoerper, DPH1 antikoerper, NCU08503 antikoerper, ATEG_01183 antikoerper, LELG_00973 antikoerper, HCAG_03806 antikoerper, AOR_1_728014 antikoerper, PTRG_05729 antikoerper, CTRG_01524 antikoerper, UREG_06411 antikoerper, BDBG_05574 antikoerper, MCYG_04396 antikoerper, PITG_12187 antikoerper, MGYG_02224 antikoerper, LOC100284663 antikoerper, dph1.L antikoerper, dph1 antikoerper, Dph1 antikoerper, dph-1 antikoerper

Hintergrund:

Synonyms: Candidate tumor suppressor in ovarian cancer 1, Diphthamide biosynthesis protein 1, Diphthamide biosynthesis protein 2 homolog like 1, Diphthamide biosynthesis protein 2 like, Diptheria toxin resistance protein required for diphthamide biosynthesis Saccharomyces like 1 , Diptheria toxin resistance protein required for diphthamide biosynthesis like 1, DPH like 1 S. cerevisiae, DPH like 1, DPH1, DPH1 homolog S. cerevisiae, DPH1 homolog, DPH2 like 1, DPH2L, DPH2L1, HsDph1, Ovarian cancer associated gene 1, Ovarian cancer associated gene 1 protein, Ovarian tumor suppressor candidate 1, DPH1_HUMAN.

Background: OVCA1 is required for the first step in the synthesis of diphthamide, a unique posttranslationally modified histidine found only in translation elongation factor-2 (EEF2, MIM 130610). This modification is conserved from archaebacteria to humans and serves as the target for ADP-ribosylation and inactivation of EEF2 by diphtheria toxin (DT) and Pseudomonas exotoxin A. OVCA1 is one of several enzymes involved in synthesis of diphthamide in EEF2.

Gen-ID: 1801